Lataa...
Sodium-glucose cotransporter 2 inhibitors and the risk of severe urinary tract infections
BACKGROUND: Prior data evaluating risk of severe UTI infections with Sodium-Glucose Co-Transporter 2 inhibitors (SGLT2i) have reported conflicting findings. OBJECTIVE: To assess whether patients initiating SGLT2i were at an increased risk of developing severe UTI events compared to those initiating...
Tallennettuna:
| Julkaisussa: | Ann Intern Med |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6989379/ https://ncbi.nlm.nih.gov/pubmed/31357213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M18-3136 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|